Universal Scientific Financials
| 601231 Stock | 15.71 0.36 2.35% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 1.3 B | 2.5 B |
|
|
Universal | Select Account or Indicator |
Understanding current and past Universal Scientific Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Universal Scientific's financial statements are interrelated, with each one affecting the others. For example, an increase in Universal Scientific's assets may result in an increase in income on the income statement.
Please note, the presentation of Universal Scientific's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Universal Scientific's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Universal Scientific's management manipulating its earnings.
Universal Scientific Stock Summary
Universal Scientific competes with Industrial, China Construction, Agricultural Bank, Bank of China, and PetroChina. Universal Scientific is entity of China. It is traded as Stock on SHG exchange.Specialization | Information Technology, Technology Hardware & Equipment |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100001BZ8 |
| Business Address | No1558, Shanghai, China, |
| Sector | Electronic Equipment, Instruments & Components |
| Industry | Information Technology |
| Benchmark | Dow Jones Industrial |
| Website | www.usiglobal.com |
| Phone | 86 21 5896 6996 |
You should never invest in Universal Scientific without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Universal Stock, because this is throwing your money away. Analyzing the key information contained in Universal Scientific's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Universal Scientific Key Financial Ratios
Universal Scientific's financial ratios allow both analysts and investors to convert raw data from Universal Scientific's financial statements into concise, actionable information that can be used to evaluate the performance of Universal Scientific over time and compare it to other companies across industries.| Revenue | 60.79 B | ||||
| Gross Profit | 3.46 B | ||||
| EBITDA | 2.87 B | ||||
| Net Income | 1.95 B | ||||
| Total Asset | 39.31 B |
Universal Scientific Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 21.9B | 31.0B | 35.9B | 38.6B | 39.3B | 20.0B | |
| Other Current Liab | 644.6M | 826.9M | 1.3B | 3.7M | 3.9M | 3.7M | |
| Other Liab | 144.8M | 223.2M | 560.4M | 516.6M | 594.1M | 623.8M | |
| Retained Earnings | 6.5B | 7.9B | 8.6B | 10.3B | 11.2B | 11.7B | |
| Accounts Payable | 7.6B | 11.2B | 11.5B | 11.1B | 10.6B | 6.6B | |
| Cash | 6.1B | 6.3B | 6.0B | 7.7B | 11.2B | 11.8B | |
| Other Assets | 608.4M | 535.1M | 647.7M | 690.9M | 794.5M | 404.0M | |
| Net Receivables | 7.4B | 10.5B | 12.5B | 11.1B | 10.0B | 6.6B | |
| Inventory | 4.3B | 6.8B | 9.0B | 10.9B | 8.3B | 4.4B | |
| Other Current Assets | 351.4M | 508.5M | 588.2M | 599.9M | 838.4M | 880.3M | |
| Total Liab | 11.6B | 18.9B | 22.8B | 22.8B | 22.2B | 11.4B | |
| Intangible Assets | 137.3M | 290.4M | 453.5M | 415.1M | 368.3M | 386.7M | |
| Net Tangible Assets | 10.1B | 10.9B | 12.1B | 13.9B | 15.9B | 10.9B | |
| Short Long Term Debt | 1.8B | 375.3M | 2.5B | 4.5B | 4.4B | 4.6B | |
| Total Current Assets | 18.2B | 24.6B | 28.5B | 30.9B | 31.0B | 23.3B | |
| Net Invested Capital | 12.1B | 15.4B | 19.8B | 23.6B | 21.4B | 17.7B | |
| Net Working Capital | 7.3B | 9.7B | 10.9B | 12.1B | 9.8B | 10.0B | |
| Capital Stock | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B | 2.4B |
Universal Scientific Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 80.8M | 90.2M | 201.3M | 235.0M | 400.2M | 420.2M | |
| Total Revenue | 37.2B | 47.7B | 55.3B | 68.5B | 60.8B | 32.9B | |
| Operating Income | 1.2B | 2.0B | 2.2B | 3.4B | 2.5B | 1.3B | |
| Cost Of Revenue | 33.5B | 42.7B | 49.8B | 61.3B | 54.9B | 29.4B | |
| Income Before Tax | 1.4B | 2.0B | 2.1B | 3.5B | 2.2B | 1.4B | |
| Net Income | 1.3B | 1.7B | 1.9B | 3.1B | 1.9B | 1.2B | |
| Income Tax Expense | 172.7M | 240.0M | 282.2M | 417.2M | 479.8M | 503.8M | |
| Research Development | 1.4B | 1.6B | 1.6B | 2.0B | 1.8B | 1.5B | |
| Gross Profit | 3.7B | 5.0B | 5.5B | 7.2B | 5.9B | 4.8B | |
| Ebit | 1.3B | 1.9B | 2.1B | 3.5B | 4.0B | 4.2B | |
| Minority Interest | 31.2M | (978.4K) | 1.3M | (22.7K) | (1.9M) | (1.8M) | |
| Tax Provision | 172.7M | 240.0M | 282.2M | 417.2M | 240.0M | 277.3M | |
| Net Interest Income | (35.6M) | (95.8M) | (203.4M) | (155.2M) | (180.0M) | (171.0M) | |
| Interest Income | 48.3M | 60.4M | 67.8M | 88.0M | 236.5M | 248.4M | |
| Ebitda | 2.0B | 2.6B | 2.3B | 4.7B | 5.4B | 2.8B |
Universal Scientific Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Universal Scientific. It measures of how well Universal is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Universal Scientific brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Universal had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Universal Scientific has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 464.6M | (1.4B) | (2.2B) | (1.9B) | 2.7B | 2.8B | |
| Dividends Paid | 420.5M | 444.2M | 1.2B | 644.4M | 1.1B | 1.2B | |
| Capital Expenditures | 673.6M | 1.1B | 1.5B | 1.7B | 1.6B | 1.7B | |
| Net Income | 1.3B | 1.7B | 1.9B | 3.1B | 1.9B | 1.2B | |
| Investments | 465.8M | (71.2M) | (75.6M) | (1.5B) | (1.2B) | (1.2B) | |
| Change In Cash | 1.5B | 220.6M | (285.0M) | 1.7B | 3.4B | 3.6B | |
| Net Borrowings | 468.4M | 149.9M | 2.2B | 3.7B | 4.3B | 4.5B | |
| Depreciation | 515.7M | 596.3M | 884.9M | 994.2M | 1.1B | 720.9M | |
| Change To Netincome | 159.7M | (106.8M) | (45.0M) | 136.0M | 156.4M | 164.2M | |
| End Period Cash Flow | 6.1B | 6.3B | 6.0B | 7.7B | 9.8B | 6.9B | |
| Free Cash Flow | 1.8B | 380.2M | (2.6B) | 1.8B | 4.8B | 5.1B | |
| Other Non Cash Items | 151.3M | 114.8M | 358.5M | 233.5M | 564.9M | 593.1M |
Universal Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Universal Scientific's current stock value. Our valuation model uses many indicators to compare Universal Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Universal Scientific competition to find correlations between indicators driving Universal Scientific's intrinsic value. More Info.Universal Scientific Industrial is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.27 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Universal Scientific Industrial is roughly 3.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Universal Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Universal Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Universal Scientific Systematic Risk
Universal Scientific's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Universal Scientific volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Universal Scientific correlated with the market. If Beta is less than 0 Universal Scientific generally moves in the opposite direction as compared to the market. If Universal Scientific Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Universal Scientific is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Universal Scientific is generally in the same direction as the market. If Beta > 1 Universal Scientific moves generally in the same direction as, but more than the movement of the benchmark.
Universal Scientific Industrial Total Assets Over Time
Universal Scientific Thematic Clasifications
Universal Scientific Industrial is part of Heavy Metals investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Industrial metals and minerals. Companies involved in mining, production, and distribution of various industrial metals and minerals
This theme covers Industrial metals and minerals. Companies involved in mining, production, and distribution of various industrial metals and minerals. Get More Thematic Ideas
| Heavy Metals | View |
Universal Scientific December 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Universal Scientific help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Universal Scientific Industrial. We use our internally-developed statistical techniques to arrive at the intrinsic value of Universal Scientific Industrial based on widely used predictive technical indicators. In general, we focus on analyzing Universal Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Universal Scientific's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.15 | |||
| Information Ratio | 0.0861 | |||
| Maximum Drawdown | 15.64 | |||
| Value At Risk | (2.98) | |||
| Potential Upside | 4.46 |
Complementary Tools for Universal Stock analysis
When running Universal Scientific's price analysis, check to measure Universal Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Scientific is operating at the current time. Most of Universal Scientific's value examination focuses on studying past and present price action to predict the probability of Universal Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Scientific's price. Additionally, you may evaluate how the addition of Universal Scientific to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |